Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05184283 · ClinicalTrials.gov registry record
Utilization of MAsS in Patients Undergoing LT for HCC
A clinical trial, sponsored by Columbia University.
- Terminated
- Registry status
- 11
- Enrollment target
NCT05184283 is a clinical trial that was terminated before completion, run by Columbia University. The registered enrollment target is 11 participants.
The verdict
NCT05184283 was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- 11 participants
- Enrollment target
Study Summary
The aim of this study is to determine the effects of liver transplantation and standard immunosuppression on body composition in patients with compensated cirrhosis and hepatocellular carcinoma.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2022-06-16 |
| Est. Completion | 2023-11-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05184283
The ClinicalTrials.gov registry entry for NCT05184283 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05184283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05184283 about?
NCT05184283 is a clinical study titled "Utilization of MAsS in Patients Undergoing LT for HCC". The aim of this study is to determine the effects of liver transplantation and standard immunosuppression on body composition in patients with compensated cirrhosis and hepatocellular carcinoma.
What is the current status of trial NCT05184283?
This trial is currently terminated. The enrollment target is 11 participants. The study started on 2022-06-16. Estimated completion is 2023-11-29.
Who is sponsoring clinical trial NCT05184283?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.